HealthTech180
  • Home
  • Activities
  • Our Team
  • Contact Us
Select Page

Hallura, an aesthetic medical company developing a new generation of Hyaluronic Acid Dermal Fillers, Closes Its $7M Financing Round

by admin | Nov 18, 2019 | Funding

Hallura Ltd., an Israeli based aesthetic medical company developing a new generation of Hyaluronic Acid (HA) Dermal Fillers, closes its A round of $7M. The financing round was led by a group of US, Europe and Israel-based private investors; most of the investment...

Shape Therapeutics raises $35.5M Series A round to develop RNA-based gene editing technology

by admin | Nov 11, 2019 | Funding

A company developing a means to edit RNA has raised more than $30 million in a venture capital funding round. Seattle-based Shape Therapeutics, or ShapeTx, said that it had raised a $35.5 million Series A financing, led by New Enterprise Associates and with...

Digital pathology startup PathAI closes $75M Series B round with investments from BMS & Merck

by admin | Nov 11, 2019 | Funding

Two of the largest drugmakers in the country are investing in a startup applying artificial intelligence in pathology. Boston-based PathAI said that it had closed its $75 million Series B financing round with funding from New York-based Bristol-Myers Squibb and the...

PierianDx raises $27M in Series B to ‘democratize’ next-generation sequencing

by admin | Nov 4, 2019 | Funding

The startup describes its software as providing clinical labs with more streamlined and accurate analysis, interpretation and reporting for accelerating personalized medicine programs. A startup that aims to provide a software-as-a-service platform to allow genomic...

Yas Holding Invests in Alvotech and Agrees on a Strategic Partnership for Biosimilar Candidates

by admin | Nov 4, 2019 | Funding, Licensing

Biopharmaceutical company Alvotech announced that Abu Dhabi-based investment company, Yas Holding, has acquired a 2.5% stake in their business and signed an agreement for the exclusive partnership and supply of three Alvotech biosimilar candidates, which Yas Holding...

Azitra brings in $14m Series A to advance microbiome skin therapies

by admin | Oct 28, 2019 | Funding

Connecticut-based microbiome therapy company Azitra recently announced a $14 million haul in Series A funding. The round was led by KdT Ventures and previous investor Bios Partners, along with Godfrey Capital and Connecticut Innovations. Azitra, which focuses on...
« Older Entries
Next Entries »
Follow Us
We are a one-stop shop Healthcare Advisory & Consulting boutique and we help businesses with funding, market access, business strategy, distribution.

Categories

Follow Us

Tags

AI Alzheimer antibodies Azitra Bioeq Biosimilar Cancer cardiovascular cell therapy CE Mark clinical trial Diagnostics Digital Health Distribution Drug Discovery Enterome EpiVax' FDA FDA approval funding fundraising HIV Immunogenicity Immunotherapies Licensing M&A medical device microbiome Neuro next-gen sequencing PathAI pathology Pepticom pharma RNA robots Shape Therapeutics skin software SurgiMab Therapeutics therapies USA VIrology Virus

Home
Activities
Our Team
Contact Us

 contact@healthtech180.com

Privacy Policy

© 2022 HealthTech180 Advisory S.L.